|
|
|
| Analysis on the Incidence of Osteoporosis and Osteopenia and The Related Influencing Factors in 1 Month Postpartum Women |
| XI Liang, LIANG Wei |
| The First Affiliated Hospital of Air Force Military Medical University, Shaanxi Xi'an 710032, China |
|
|
|
|
Abstract Objective: To analyze the incidence of osteoporosis and osteopenia and the related influencing factors in 1 month postpartum women. Methods: The clinical data of 100 cases of parturient in our hospital were studied retrospectively. According to the measurement results of BMD in one month after delivery, the parturient were divided into group A (normal bone mass), group B (decreased bone mass) and group C (osteoporosis). The age, gestational age, gestational times, birth times, body mass index (BMI), birth weight of newborn, family history of osteoporosis, milk intake per week during pregnancy and calcium supplement of the three groups were compared. The influencing factors of postpartum osteoporosis were analyzed by multivariate logistic regression. Results: Of the 100 cases, 57 (57.00%) had normal bone mass, 35 (35.00%) had decreased bone mass and 8 (8.00%) had osteoporosis. There was no significant difference between the three groups in terms of age, pregnancy, birth and birth weight (P>0.05). There were significant differences among the three groups in BMI, family history of osteoporosis, milk intake per week during pregnancy and calcium supplementation after childbirth (P<0.05). Multiple logistic regression analysis showed that BMI < 18.5 kg/m2, family history of osteoporosis and no calcium supplementation were independent risk factors of osteoporosis (P<0.05). Conclusion: The decrease of bone mass and osteoporosis account for a certain proportion in the women one month after delivery, which is closely related to the factors such as low BMI, family history of osteoporosis, lack of calcium supplementation after delivery. It is suggested that postpartum calcium supplementation and maintenance of BMI in the normal range should be paid attention to, at the same time, the monitoring of bone density value should be strengthened, and osteoporosis should be diagnosed timely, treated and intervened as soon as possible.
|
|
|
|
|
|
[1] 王丽钗.围绝经期雌激素水平与骨质疏松关系的研究[J].中国基层医药,2019,25(6):705~708.
[2] 张义龙,唐佩福.骨质疏松性椎体压缩骨折的治疗进展[J].河北医学,2017,23(8):1398~1401.
[3] Zhang M, Chen P, Li B, et al. Approach to the patient with pregnancy and lactation-associated osteoporosis: a case report and a review of the literature [J]. Medicine (Baltimore),2017,96(46):e8671.
[4] Gehlen M, Lazarescu AD, Hinz C, et al. Pregnancy and lactation-associated osteoporosis[J]. Z Rheumatol,2017,76(3):274~278.
[5] Zhou Y, Zhu X, Zhang M,et al. Association between dietary inflammatory index and bone density in lactating women at 6 months postpartum: a longitudinal study[J].BMC Public Health,2019,19(1):1076.
[6] Hardcastle SA, Yahya F, Bhalla AK.Pregnancy-associated osteoporosis: a UK case series and literature review[J].Osteoporos Int,2019,30(5):939~948.
[7] 刘庆波,梁甜,熊怀风. 妊娠及哺乳期骨质疏松的临床表现及护理要点[J]. 医学信息,2017,30(3):178~179.
[8] Hong N, Kim JE, Lee SJ,et al.Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy and lactation-associated osteoporosis[J]. Clin Endocrinol (Oxf),2018,88(5):652~ 658.
[9] Yun KY, Han SE, Kim SC, et al. Pregnancy-related osteoporosis and spinal fractures[J]. Obstet Gynecol Sci,2017,60(1):133~137.
[10] Ishibashi H. Prevention of osteoporosis during pregnancy and lactation period[J].Clin Calcium,2019,29(1):85~91. |
|
|
|
2020, Vol. 26 
